The Discounted Cash Flow (DCF) valuation of West Pharmaceutical Services Inc (WST) is 311.39 USD. With the latest stock price at 279.78 USD, the upside of West Pharmaceutical Services Inc based on DCF is 11.3%.
Based on the latest price of 279.78 USD and our DCF valuation, West Pharmaceutical Services Inc (WST) is a buy. buying WST stocks now will result in a potential gain of 11.3%.
| Range | Selected | |
| WACC / Discount Rate | 6.6% - 8.5% | 7.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 209.64 - 654.99 | 311.39 |
| Upside | -25.1% - 134.1% | 11.3% |